Furthermore, the inhibition of CBS leads to anti-tumor activity especially in breast cancer, ovarian cancer, and colon cancer, while the effect of CSE or 3-MST inhibition has been largely unexplored in cancer cells. This evidence concerns the gene CTH and cancer.